Pharmacy Law Practice Exam Questions

Which of the following statements is (are) accurate concerning the transferring of prescriptions? I. Non-controlled prescriptions may be transferred as many times as there are authorized refills on the prescription. II. CII prescriptions may be transferred only one time. III. Pharmacy technicians may process the prescription transfer in Kansas. a. I only b. III only c. I & II only d. II & III only e. I, II, & III

I. Non-controlled prescriptions may be transferred as many times as there are authorized refills on the prescription.

Child Resistant &/or Patient Package Insert? nitroglycerin 0.4mg, S.L. tablets

Requires NEITHER child-resistant packaging nor a patient-package insert

Child Resistant &/or Patient Package Insert? Haloperidol liquid concentrate, 15ml, dispensed in dropped bottle

Requires child-resistant packaging and NO patient-package insert

Child Resistant &/or Patient Package Insert? isosorbide dinitrate 40mg sustained release tablets, #100

Requires child-resistant packaging and NO patient-package insert

Child Resistant &/or Patient Package Insert? potassium chloride liquid 10%, 16 oz

Requires child-resistant packaging and NO patient-package insert

Child Resistant &/or Patient Package Insert? Ovral-28, 1 month

Requires patient-package insert and NO child-resistant packaging

Child Resistant &/or Patient Package Insert? Prempro™ dial pack

Requires patient-package insert and NO child-resistant packaging

18VAC110-20-330 Labeling of prescription as to content and quantity Label requirements:

1. Drug name and strength a. For any drug product possessing a single active ingredient, the generic name of the drug shall be included on the label. b. If a generic drug is dispensed when a prescription is written for a brand drug, the words "generic for" are required. c. The requirements of subdivisions 1 a and b of this section shall not apply to drugs dispensed to patients of a hospital or long term care facility where all drugs are administered by persons licensed to administer. 2. The number of dosage units or, if liquid, the number of milliliters dispensed.

Any drug dispensed by filling or refilling a written or oral prescription of a prescriber shall be exempt from the requirements of § 54.1-3462 except subdivisions 1, 9, and 10, and the packaging requirements of subdivision 7, if the drug bears a label containing what 8 things?

1. The name of the dispenser 2. address of the dispenser 3. serial # 4. Date of prescription or of its filling 5. Prescriber's name 6. Patient's name 7. Directions for use 8. cautionary statements, if any

Pharmacies in which bulk reconstitution if injectable, bulk compounding or the repackaging or prepackaging of drugs is performed shall maintain adequate control records for a period of ______ or until the expiration, whichever is greater. List the requirements of this record

1. drug(s) used 2. strength 3. date repackaged 3. quantity prepared 4. initials of the pharmacist 5. assigned lot or control number 6. manufacturer's or distributor's name and lot or control number 7. expiration date.

The total number of dosage units of all controlled substances distributed to DEA registrants by a practitioner during the twelve-month calendar year in which the practitioner is registered to dispense cannot exceed ___ percent of the total number of dosage units of all controlled substances distributed and dispensed during this time period.

5%

A pharmacy must limit the OTC sales of pseudoephedrine tablets to no more than ____ grams (of base) per purchaser per 30 days.

9 grams

A prescriber may issue multiple prescriptions authorizing a patient to receive a total of up to a ___-day supply of CII medication providing the prescriber writes specific directions on each prescription indicating the earliest date it may be filled and no pharmacist fills it before that date.

90 day

Which of the following circumstances would be considered "adulteration"? A. A drug is prepared and packaged under unsanitary conditions B. The drug's manufacturing procedures do not conform to GMP standards C. The drug is subject to the Poison Prevention Packaging Act and is not packaged accordingly. A, and b A, b, and c

A, and b

Which of the following is true regarding Schedule III controlled substances? A. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence B. The drug or other substance has no currently accepted medical use in treatment in the United States C. The drug or other substance has a high potential for abuse D. The drug or other substance has a potential for abuse higher than the drugs or other substances in schedules I and II.

A. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence

Prescription orders for a Schedule II drug may only be faxes in which circumstances? a. long term care facilities b. for patients who were just discharged from a hospital with a hard copy. c. A and B d. None of the above

A. Long term care facilities

Adulteration is about ___, ____, and _____ of the product A. strength, purity, quality B. Safety, effectiveness, quality C. Filth, putrid, or decomposed substances D. labeling, identity, mislabeling

A. strength, purity, quality

All of the following must be included on the written prescription from a veterinarian EXCEPT: A. Full name, address of owner of the animal B. Species of animal C. Animal's name D. Dated and signed by practitioner on the date of issue

C. Animal's name

Which of the following is required in getting a new indication for a drug that is already approved? A. Investigational New Drug Application B. New drug application C. Supplement New Drug Application D. Abbreviated New drug application

C. Supplement New Drug Application

All of the following have authority to prescribe EXCEPT: A. TPA-certified optometrist B. Nurse practitioner C. Physician's assistant D. chiropractor

D. chiropractor

When is the warning "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed." required to appear on the label of dispensed prescriptions?

Dispensing of schedule II, III, IV

Which of the following is/are accurate concerning the dispensing of hypodermic needles? a. The person requesting such item must provide legitimate purpose for use b. The price at which it was sold must be recorded c. Record showing the name and quantity of the device d. A and c only e. A, b, and c

E. A, B, and C

Child Resistant &/or Patient Package Insert? Anhydrous cholestyramine powder

Requires NEITHER child-resistant packaging nor a patient-package insert

Child Resistant &/or Patient Package Insert? isosorbide dinitrate 5mg sublingual tablets, #100

Requires NEITHER child-resistant packaging nor a patient-package insert

Child Resistant &/or Patient Package Insert? methylprednisolone dosepak

Requires NEITHER child-resistant packaging nor a patient-package insert

The emergency room of a hospital may provide an interim supply of prepackaged drugs to an outpatient on order of a physician when a pharmacist is not on the premises. The interim supply is limited to what quantity?

Sufficient supply until a prescription can be filled

When a DEA inspector conducts an audit of your controlled substances, what percent error are you allowed? a. 0% b. 3% c. 5% d. 10%

a. 0%

Dispensing a C-V, OTC cough syrup containing codeine is limited to which of the following? a. 120 ml within 48 hours b. 180 ml within 48 hours c. 240 ml within 48 hours d. No limitation if Barb Woods needs it!

a. 120 ml within 48 hours

As the pharmacist-in-charge of a retail pharmacy that is owned by a non-pharmacist, you are responsible for notifying the Board in writing within what period of time if you decide to quit as the pharmacist-in-charge? a. 5 days b. 10 days c. 14 days d. None of the above

a. 5 days

On a controlled substance inventory, opened containers with which of the following drugs must be counted exactly? a. CIIs b. CII, CIII, and CIVs in any size of container c. All controlled substances d. Only CII, CIII, and CIVs in opened containers

a. CIIs

The FDA has notified Slipshod Pharmaceutical Manufacturer that several lots of their OTC analgesics have been found to be contaminated with digitoxin and present serious threat to patients' safety. The FDA is likely to request that Slipshod announce which class of drug recall? a. Class I b. Class II c. Class III d. Class IV

a. Class I

Which of the following situations may require a pharmacy to register with the FDA, be subject to FDA inspections, and comply with CGMP? a. Community pharmacist compounds large bulk quantities of inhaler solution and ships the product to numerous out-of-state pharmacies for dispensing. b. Hospital pharmacy repackages and relabels a drug product in unit-dose packaging for routine use for inpatients. c. Community pharmacist compounds drugs in anticipation of prescription drug orders based on routine prescribing patterns. d. a and b e. a, b, and c

a. Community pharmacist compounds large bulk quantities of inhaler solution and ships the product to numerous out-of-state pharmacies for dispensing.

Which FDCA amendment exempted certain drugs from the "adequate directions for use" labeling requirement if they bear "Rx only" on their labels? a. Durham Humphrey b. Kefauver-Harris c. Prescription Drug Marketing d. Waxman-Hatch

a. Durham Humphrey

According to the FDA Compliance Policy Guide, which of the following pharmacy activities does the FDA consider to be traditional pharmacy activity that is NOT subject to FDA enforcement? a. Extemporaneously compounding medication on receipt of a valid prescription from a licensed practitioner for an individual patient. b. Compounding a medication from components that have not been determined to meet official compendial requirements. c. Compounding drugs for third parties who resell the drugs to individual patients. d. Compounding drugs that have been withdrawn from the market due to safety concerns

a. Extemporaneously compounding medication on receipt of a valid prescription from a licensed practitioner for an individual patient.

A "brick and mortar" pharmacy operates an Internet site that provides advertising for pharmacy services, provides some patient educational material, and accepts non-controlled prescription and OTC orders. Orders received from the Internet site are dispensed from inventory located in the physical pharmacy. Which of the entities must be registered with the DEA? a. The "brick and mortar" pharmacy b. The Internet site c. a and b d. Neither a nor b

a. The "brick and mortar" pharmacy

The purpose of DESI was to prove efficacy of prescription and OTC drugs that were marketed: a. between 1938 and 1962. b. before 1938. c. after 1962. d. none of the above.

a. between 1938 and 1962.

Ipecac syrup, dispensed in a 4 ounce bottle to patient, is considered to be a(n): a. prescription drug and dispensed only upon prescriptive authorization. b. OTC drug and labeled accordingly. c. OTC drug and labeled with specific FDA labeling requirements.

a. prescription drug and dispensed only upon prescriptive authorization.

According to the Prescription Drug marketing Act of 1987, no person may sell, purchase, or trade: a. prescription drug samples. b. OTC drug samples. c. starter packages of prescription drugs. d. a and b e. a, b, and c

a. prescription drug samples.

It is not necessary to dispense an oral prescription drug for human use in a child-resistant container if the: I. patient requests standard packaging. II. prescriber requests standard packaging on the prescription for a specific patient. III. prescriber requests a blanket waiver for child-resistant packaging for all of the prescriptions of one patient. IV. pharmacist, in his/her professional judgment, deems it is not necessary. a. I b. I and II c. II and III d. II, III and IV

b. I. patient requests standard packaging. II. prescriber requests standard packaging on the prescription for a specific patient.

What is the maximum number of different OTC drugs that may be offered for sale through one vending machine? a. 5 b. 12 c. 20 d. 25

b. 12

Annually, a pharmacy dispenses by prescription 100,000 dosage units of controlled substances. Without obtaining registration as a distributor, the pharmacy can distribute to other registrants a maximum of how many dosage units? a. 2500 b. 5000 c. 7500 d. 10,000

b. 5000

If a pharmacist uses the 2-drawer manual filing system (not the computer) for storing controlled substance prescriptions as the primary method, which of the following schedules of medication should be marked with a red "C"? a. All CIIs b. CIII, CIV, and CVs c. CIII and CIV only d. All non-controlled prescriptions

b. CIII, CIV, and CVs

The statement: "Caution: Federal law prohibits the transfer of this drug to any person other than the person for whom it was prescribed." Must appear on prescription medication containers which contain controlled substances in the following schedules EXCEPT: a. CIII b. CV c. CII d. CIV e. It must be on containers of all of the above schedules.

b. CV

Ipecac syrup, dispensed in 15-30ml unit-dose containers and labeled according to FDA requirements, may be considered: a. prescription only. b. OTC.

b. OTC.

The authority to grant practitioners a license to prescribe drugs resides with: a. the federal government b. the state government c. the local district court d. none of the above

b. the state government

Which of the following might represent a breach of privacy based on federal HIPAA? I. Allowing a pharmaceutical sales representative to peruse your prescription files to ascertain of a certain doctor is prescribing a new antidepressant. II. Providing a husband with a list of drug products and their therapeutic uses that his wife received last year. III. Allowing a pharmacy clerk to call out the names of waiting patients to pick up their prescriptions. a. I only b. III only c. I & II only d. II & III only e. I, II, & III

c. I. Allowing a pharmaceutical sales representative to peruse your prescription files to ascertain of a certain doctor is prescribing a new antidepressant. II. Providing a husband with a list of drug products and their therapeutic uses that his wife received last year.

Controlled substance records that must be kept at the registration site include: I. Invoices for controlled substance purchases. II. Controlled substance prescriptions. III. Controlled substance inventory records IV. Executed DEA Form-222s a. I and II b. I, II, and III c. II, III, and IV d. I, II, III and IV

c. II. Controlled substance prescriptions. III. Controlled substance inventory records IV. Executed DEA Form-222s

After a pharmacy purchaser completes a DEA Form-222, which copy does the pharmacy retain? a. Copy 1 b. Copy 2 c. Copy 3 d. Copies 1 and 2

c. Copy 3

The advertising of OTC products is regulated primarily by: a. FDA b. HHS c. FTC d. DEA

c. FTC

Dr. Johns would also like to continue Susan on this medication for two more weeks. Which of the following is true? a. He may write on the prescription he sends to you for the emergency period for a total of 45 doses. b. He may authorize and you may fill 2 refills on the emergency prescription you wrote. c. He must give you two prescriptions: one covering #15 doses for the emergency time and one for the additional doses. d. You may alter the emergency prescription to reflect the additional doses and have him sign his name on it.

c. He must give you two prescriptions: one covering #15 doses for the emergency time and one for the additional doses.

While employed as a hospital pharmacy intern, you routinely repackage commercially available prescription drugs into USP-quality unit-dose containers. On January 1, 2011, you repackage Killacillin 200mg that carries an expiration date on the container of January 2, 2013. According to FDA recommendations, which expiration date should you place on the unit-dose packages? a. February 1, 2011 b. April 1, 2011 c. January 1, 2012 d. July 1, 2011 e. January 2, 2013

c. January 1, 2012

The expiration date on the manufacturer's label of a prescription drug is July 2011. The pharmacist should consider the expiration of this drug to be: a. July 1, 2011 b. July 15, 2011 c. July 31, 2011 d August 1, 2011

c. July 31, 2011

All of the following practice activities must be performed by a licensed pharmacist EXCEPT: a. Performing drug regimen reviews. b. Interpreting and verifying patient medication records. c. Prepackaging medications in unit-dose containers. d. Ensuring the proper selection of prescription drugs, devices or suppliers.

c. Prepackaging medications in unit-dose containers.

The minimum necessary requirement for disclosing PHI does NOT apply to: a. Payment for services b. Marketing activities c. Treatment activities d. a and c

c. Treatment activities

A pharmacist can fill a prescription for methadone for what medical reason? a. maintenance of a patient's addiction. b. detoxification of an addicted patient. c. analgesic purposes. d. a and c

c. analgesic purposes.

According to DEA regulations, all of the following information is required for recording an OTC CV sale, EXCEPT: a. name and address of purchaser b. name and quantity of drug c. intended use of the drug d. date of sale of the drug e. name or initials of dispensing pharmacist

c. intended use of the drug

Dolittle Pharmacy needs to order the following medications from their drug wholesaler. diazepam 10mg tablets 2 bottles of 100 codeine sulfate 30mg tabs 4 bottles of 100 Fioricet tabs 1 bottle of 100 Fiorinal tabs 2 bottles of 100 Dilaudid 2mg/ml inj. 5 boxes of 25 amps methadone 5mg tabs 2 bottles of 100 Tylox caps. 1 bottle of 100 Lomotil liquid 2.5mg/5ml 1 bottle of 60ml Which of the above drugs must be ordered from the wholesaler using a DEA-222 form?

codeine sulfate tabs Dilaudid inj. methadone tabs Tylox

Which of the following are DEA-authorized methods that a pharmacist may use to file hardcopy controlled and noncontrolled substance prescriptions? I. All prescriptions are filed together with CII prescriptions stamped with a red "C". II. CII prescriptions in one file; CIII, CIV, and CV prescriptions in another file; Non-controlled prescriptions in a third file. III. CII prescriptions in one file; CIII, CIV and CV and non-controlled prescriptions together. a. I only b. III only c. I & II d. II and III e. I, II, & III

d. II. CII prescriptions in one file; CIII, CIV, and CV prescriptions in another file; Non-controlled prescriptions in a third file. III. CII prescriptions in one file; CIII, CIV and CV and non-controlled prescriptions together.

Which of the following are true concerning pharmacists' continuing education requirements in Kansas? I. One CEU is equal to one contact hour. II. Thirty contact hours are required biennially for re-licensure. III. Failure to supply the Board of Pharmacy evidence of adequate CE will cause one's license to become inactive. a. I only b. III only c. I & II only d. II & III only e. I, II, & III

d. II. Thirty contact hours are required biennially for re-licensure. III. Failure to supply the Board of Pharmacy evidence of adequate CE will cause one's license to become inactive.

Dr. Johns, a DEA-registered internist, calls on Friday evening requesting that you dispense #15 Levo-Dromoran tablets to Susan Folkes. You are satisfied that the situation is an emergency. Dr. Johns must supply you with a signed prescription within how much time? a. 72 hours b. 96 hours c. 5 days d. 7 days

d. 7 days

Which of the following circumstances would be considered "adulteration" under the FDCA? a. A drug is prepared and packaged under unsanitary conditions. b. The drug's manufacturing procedures do not conform to GMP standards. c. The drug is subject to the Poison Prevention Packaging Act and is not packaged accordingly. d. a and b e. a, b and c

d. A drug is prepared and packaged under unsanitary conditions, The drug's manufacturing procedures do not conform to GMP standards.

Who has primary authority on the federal level for the scheduling, rescheduling, or de-scheduling of controlled substances? a. DEA b. FDA c. Attorney General d. Attorney General in conjunction with the Secretary of Health and Human Services

d. Attorney General in conjunction with the Secretary of Health and Human Services

Which statement is correct about dispensing a drug for a use that is unapproved by the FDA? a. It is illegal for a pharmacist to dispense a prescription for an unapproved use. b. It is illegal only if the pharmacist is aware that it is for an unapproved use. c. It is illegal if the use varies significantly from the regular usage (in terms of dose, etc.) d. It is legal to dispense a medication for an unapproved use.

d. It is legal to dispense a medication for an unapproved use.

When a manufacturer refuses to recall its violative drug product at the request of the FDA, which of the following legal remedies is available to the FDA? a. Publicity b. Injunction c. FDA-initiated recall d. Seizure of the product

d. Seizure of the product (New Law - FDA can order a recall??)

Pharmacist Van received a methylphenidate prescription that was dated March 1, 2011. On what date is this prescription no longer valid in Kansas? a. March 8, 2011 b. April 15, 2011 c. June 2, 2011 d. September 2, 2011

d. September 2, 2011

Which of the following statements is accurate concerning NDC numbers? a. The FDA requires all commercial products to carry NDC numbers. b. NDC number identifies the drug, strength, and size of package and is frequently used for third-party claims submission. c. An NDC indicates that the drug has received NDA approval. d. a and b e. a, b, and c

d. The FDA requires all commercial products to carry NDC numbers; NDC number identifies the drug, strength, and size of package and is frequently used for third-party claims submission

Which of the following statements is(are) accurate concerning the dispensing of OTC CV cough preparations? a. The customer must be at least 18 years old. b. The pharmacy technician may complete the entire transaction, including the dispensing, under the supervision of a pharmacist. c. The purchaser must present suitable identification to the pharmacist if he or she is unknown to the pharmacist. d. a and c

d. The customer must be at least 18 years old ; The purchaser must present suitable identification to the pharmacist if he or she is unknown to the pharmacist.

Under which of the following circumstances does the pharmacist need to notify the DEA? a. The pharmacy was robbed and CIIs and 222 forms were taken. b. The pharmacy is planning to move to a new location. c. The owner (sole proprietor) of a community pharmacy dies. d. All of the above.

d. The pharmacy was robbed and CIIs and 222 forms were taken; The pharmacy is planning to move to a new location; The owner (sole proprietor) of a community pharmacy dies.

According to the Poison Prevention Packaging Act of 1970, a pharmacist may reuse: a. a glass container on a prescription refill, provided a new child-resistant closure is used. b. plastic non-child-resistant containers and lids on prescriptions for which the patient has requested waiver. c. plastic child-resistant containers and lids on prescription refills. d. a and b e. a, b and c

d. a glass container on a prescription refill, provided a new child-resistant closure is used, plastic non-child-resistant containers and lids on prescriptions for which the patient has requested waiver.

Which of the following has/have the authority to sign a triplicate DEA Form-222 in order to obtain CII drugs from another registrant? a. a pharmacist or non-pharmacist, as designated in a current and properly executed power of attorney. b. the pharmacist or non-pharmacist, who signed the most recent DEA application for a controlled substance registration. c. a pharmacist who has received verbal authorization from the owner or manager of a pharmacy registrant. d. a and b e. a, b and c

d. a pharmacist or non-pharmacist, as designated in a current and properly executed power of attorney; the pharmacist or non-pharmacist, who signed the most recent DEA application for a controlled substance registration.

In order to serve on the Kansas State Board of Pharmacy, you must: a. be a resident of Kansas. b. have been actively engaged in the practice of pharmacy in Kansas for 5 years prior to appointment. c. have had your name submitted to the governor by the Kansas Pharmacist Association. d. a and b only e. a, b, and c

d. be a resident of Kansas; have been actively engaged in the practice of pharmacy in Kansas for 5 years prior to appointment.

Which of the following prescription medications can be mailed by a community pharmacy through the US Postal Service to a patient? a. meperidine 50 mg tablets b. diazepam 10 mg injections c. methylphenidate 5mg tablets d. all of the above

d. meperidine 50 mg tablets; diazepam 10 mg injections; methylphenidate 5mg tablets

A patient requests a refill of his prescription for diphenoxylate 2.5mg/Atropine sulfate 0.025mg. What are the limitations for refilling this prescription (with appropriate authorization) in Kansas? a. no refills permitted b. maximum of 5 refills c. maximum of 5 refills or 6 months, whichever comes first d. one year from the date of issuance

d. one year from the date of issuance

A physician develops a product to relieve oral discomfort in cancer patients. He has a number of colleagues who are interested in using the product and asks you to compound it so that he may ship it to his colleagues in other states. He will supply you with a prescription marked "For Office Use" for a very large quantity of the preparation. The FDA would likely: a. view this a marketing a new drug without an approved NDA. b. view you as a manufacturer. c. consider your activities as being within the normal course of pharmacy practice. d. Both a and b

d. view this a marketing a new drug without an approved NDA; view you as a manufacturer.

It is within an opthalmologist's scope of practice to prescribe: I. Acetazolamide (Diamox) II. Sodium Sulfacetamide solution 10% III. Oxycodone 2.5mg/APAP 325mg a. I only b. III only c. I and II only d. II and III only e. I, II and III

e. I. Acetazolamide (Diamox) II. Sodium Sulfacetamide solution 10% III. Oxycodone 2.5mg/APAP 325mg

Which of the following activities is (are) the responsibility of a pharmacist-in-charge of a community pharmacy? I. Develop or approve written policies and procedures for the pharmacy. II. Maintain records in the pharmacy describing the training and education regarding work functions performed by all pharmacy personnel. III. Inventory all controlled substances in the pharmacy within 72 hours after beginning to function as the PIC. a. I only b. III only c. I & II only d. II & III only e. I, II, & III

e. I. Develop or approve written policies and procedures for the pharmacy. II. Maintain records in the pharmacy describing the training and education regarding work functions performed by all pharmacy personnel. III. Inventory all controlled substances in the pharmacy within 72 hours after beginning to function as the PIC.

A physician's assistant may legally perform which of the following activities under written protocol with a responsible physician? I. May directly administer a prescription drug. II. May prescribe a CII drug by oral or telephonic communication in an emergency. III. May prescribe a CIII, CIV, or CV drug in writing. a. I only b. III only c. I & II only d. II & III only e. I, II, & III

e. I. May directly administer a prescription drug. II. May prescribe a CII drug by oral or telephonic communication in an emergency. III. May prescribe a CIII, CIV, or CV drug in writing.

A pharmacist must send a copy of each of the following documents to the regional DEA office EXCEPT: I. Power of Attorney II. Most recent controlled substance inventory III. State pharmacy registration a. I only b. III only c. I and II only d. II and III only e. I, II and III

e. I. Power of Attorney II. Most recent controlled substance inventory III. State pharmacy registration

Which of the following circumstances would be considered "misbranding" under the FDCA? a. A drug's label or labeling is false or misleading. b. A prescription for a legend drug is refilled without the prescriber's authorization. c. A drug is subject to the Poison Prevention Packaging Act is not packaged accordingly. d. a and b e. a, b and c

e. A drug's label or labeling is false or misleading, A prescription for a legend drug is refilled without the prescriber's authorization, A drug is subject to the Poison Prevention Packaging Act is not packaged accordingly.

Which of the below practitioners may apply for and receive a DEA registration number in Kansas? a. Dentists b. Surgeons c. Optometrists d. a and b only e. a, b and c

e. Dentists; Surgeons; Optometrists

Which items is(are) included in the definition of "unprofessional conduct" stated in the Kansas Pharmacy Practice Act? a. Fraud when applying for registration or a permit. b. Intentionally falsifying or altering prescriptions. c. Unlawful diversion of drugs to others. d. Intentionally adulterating any drug. e. All of the above.

e. Fraud when applying for registration or a permit; Intentionally falsifying or altering prescriptions; Unlawful diversion of drugs to others; Intentionally adulterating any drug.

Which of the below is(are) officially recognized by the FDCA? a. USP/DI b. USP/NF c. Homeopathic Pharmacopeia d. a and b e. b and c

e. USP/NF, Homeopathic Pharmacopeia

6. The label on the container of an OTC drug intended for sale directly to a patient must include: a. adequate directions for safe and effective use. b. cautions and warnings needed for the protection of the user. c. net contents of the package d. name and address of the manufacturer, packer, or distributor e. all of the above f. only a, b and c

e. adequate directions for safe and effective use; cautions and warnings needed for the protection of the user; net contents of the package; name and address of the manufacturer, packer, or distributor

When a pharmacist leaves the premises of a community pharmacy, a pharmacy intern may: a. continue to fill prescriptions as long as none are dispensed. b. take prescription transfers from other pharmacies. c. hand prescriptions to patients as long as they are refills and were filled by the pharmacist. d. a and c e. do none of the above.

e. do none of the above

CIII and CIV controlled substance prescriptions may be partially filled, provided: a. no dispensing occurs after 6 months from the date the prescription was issued. b. the total quantity dispensed in all partial fillings does not exceed the total quantity prescribed. c. each partial filling is recorded in the same manner as a refilling. d. a and b e. a, b, and c

e. no dispensing occurs after 6 months from the date the prescription was issue; the total quantity dispensed in all partial fillings does not exceed the total quantity prescribed; each partial filling is recorded in the same manner as a refilling.

In general, CII controlled substance prescriptions may be partially filled provided: a. no dispensing occurs after 72 hours from the date it was partially filled. b. the pharmacist is unable to supply the full quantity. c. the quantity dispensed in the partial fill is recorded on the face of the prescription or in the computer record d. a and b e. a, b, and c

e. no dispensing occurs after 72 hours from the date it was partially filled; the pharmacist is unable to supply the full quantity; the quantity dispensed in the partial fill is recorded on the face of the prescription or in the computer record

A properly executed power of attorney: a. automatically expires in three years with the registration. b. authorizes an individual to sign any legal document on behalf of the person granting power of attorney. c. must be notarized. d. must be photocopied and the photocopy sent to the regional DEA office. e. none of the above.

e. none of the above.

When a pharmacy repackages a drug product in unit-dose packages, a record should be maintained which includes among other things the: a. pharmacy's identification number if different from the manufacturer's lot number. b. product's manufacturer or supplier. c. expiration date of the original container. d. a and b e. a, b, and c

e. pharmacy's identification number if different from the manufacturer's lot number, product's manufacturer or supplier, expiration date of the original container.

The FDCA defines a "new drug" as a previously approved drug entity with a new: a. route of administration. b. indication for use. c. combination of ingredients. d. a and b e. a, b and c.

e. route of administration, indication for use, combination of ingredients.

True or False: An insulin containing drug is deemed misbranded if it is not from a batch for which a certificate or release has been issued.

true: "9. If it is, or purports to be, or is represented as a drug composed wholly or partly of insulin, unless it is from a batch for which a certificate or release has been issued pursuant to § 506 of the federal act, and such certificate or release is in effect with respect to such drug."